無料プレビュー

Zoetis Inc. (ZTS) · New York Stock Exchange

プロフィール

Zoetis Inc. is a global leader in animal health focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, biodevices, genetic tests, and precision animal health solutions. The company offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and animal health diagnostics across eight core species: dogs, cats, horses, cattle, swine, poultry, fish, and sheep. Zoetis operates through two reportable segments: United States and International, with products distributed to veterinarians, pet owners, and lives

主要指標

株価: $73.08 (+2.14%)
時価総額: 306億ドル
PER（今期予想）: 11.7
PBR: 9.7
配当利回り: 2.86%
52週レンジ: $68.77 – $148.30
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: S&P 500 0.04%

比較会社: MRK Merck & Co., Inc.、TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、IDXX IDEXX Laboratories, Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.、CTLT Catalent, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-05 · 更新: 2026-10-08